Sionna Therapeutics (SION) Non-Current Assets (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Non-Current Assets data on file, last reported at $84.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 12.41% year-over-year to $84.1 million; the trailing twelve-month figure through Mar 2026 stood at $340.9 million (changed N/A YoY), and the FY2025 full-year result was $84.5 million, up 143.2% from the prior year.
• Non-Current Assets slipped to $84.1 million in Q1 2026, from $84.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $96.0 million in Q1 2025 to a low of $34.8 million in Q4 2024.
• A 3-year average of $78.6 million and a median of $84.9 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 143.2% in 2025 and dropped 12.41% in 2026, its largest moves.
• Tracing SION's Non-Current Assets over 3 years: stood at $34.8 million in 2024, then soared by 143.2% to $84.5 million in 2025, then retreated by 0.54% to $84.1 million in 2026.
• Business Quant data shows SION's Non-Current Assets at $84.1 million in Q1 2026, $84.5 million in Q4 2025, and $86.9 million in Q3 2025.